Chlorite In The Treatment Of Neurodegenerative Disease


The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.

Download PDF
Document Preview
Document History
  • Publication: Aug 25, 2005
  • Application: Jan 25, 2005
    WO US 2005/0002469 W
  • Priority: Feb 3, 2004
    US US 54157604 P

Download Citation

Sign in to the Lens